185 related articles for article (PubMed ID: 27072256)
1. The retrospective analysis of patients with uterine sarcomas: A single-center experience.
Terek MC; Akman L; Hursitoglu BS; Sanli UA; Ozsaran Z; Tekindal MA; Dikmen Y; Zekioglu O; Ozsaran AA
J Cancer Res Ther; 2016; 12(1):309-13. PubMed ID: 27072256
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of patients with uterine sarcomas.
Sharma DN; Rath GK; Kumar S; Kumar L; Bhatla N; Gandhi AK; Hariprasad R
J Cancer Res Ther; 2011; 7(3):270-4. PubMed ID: 22044806
[TBL] [Abstract][Full Text] [Related]
3. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
[TBL] [Abstract][Full Text] [Related]
4. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
[TBL] [Abstract][Full Text] [Related]
5. [Uterine sarcoma in Tunisia: retrospective study about 14 cases].
Bouzid N; Kanoun Belajouza S; Boussen H; Bouaouina N
Gynecol Obstet Fertil; 2014 Dec; 42(12):838-43. PubMed ID: 25155830
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia].
Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H
Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649
[TBL] [Abstract][Full Text] [Related]
7. The role of adjuvant radiation in uterine sarcomas.
Sampath S; Schultheiss TE; Ryu JK; Wong JY
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):728-34. PubMed ID: 19700247
[TBL] [Abstract][Full Text] [Related]
8. Results of postoperative radiotherapy in the treatment of uterine sarcomas: a retrospective analysis of 46 patients.
Yalman D; Ozsaran Z; Baltalarli B; Demir O; Ozdemir N; Aras A
Eur J Gynaecol Oncol; 2008; 29(1):46-51. PubMed ID: 18386463
[TBL] [Abstract][Full Text] [Related]
9. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
Dusenbery KE; Potish RA; Argenta PA; Judson PL
Am J Clin Oncol; 2005 Jun; 28(3):295-300. PubMed ID: 15923804
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy in early stage uterine sarcomas: an open question.
Gadducci A; Romanini A
Eur J Gynaecol Oncol; 2001; 22(5):352-7. PubMed ID: 11766739
[TBL] [Abstract][Full Text] [Related]
11. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus.
Dusenbery KE; Potish RA; Judson P
Gynecol Oncol; 2004 Jul; 94(1):191-6. PubMed ID: 15262141
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1277-87. PubMed ID: 18506484
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
[TBL] [Abstract][Full Text] [Related]
14. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
15. [Uterine sarcomas: clinical and therapeutic aspects (10 cases)].
Hassini A; Khemiri B; Sfar E; Chelly D; Chennoufi MB; Chelly H
J Gynecol Obstet Biol Reprod (Paris); 2006 Jun; 35(4):348-55. PubMed ID: 16940904
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients.
Mancari R; Signorelli M; Gadducci A; Carinelli S; De Ponti E; Sesana S; Corso S; Chiappa V; Colombo N; Lissoni AA
Gynecol Oncol; 2014 Jun; 133(3):531-6. PubMed ID: 24631454
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.
Odunsi K; Moneke V; Tammela J; Ghamande S; Seago P; Driscoll D; Marchetti D; Baker T; Lele S
Int J Gynecol Cancer; 2004; 14(4):659-64. PubMed ID: 15304162
[TBL] [Abstract][Full Text] [Related]
18. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
19. Uterine sarcoma-current management and experience from a regional cancer centre in North India.
Biswas A; Patel F; Kumar P; Srinivasan R; Bera A; Sharma SC; Rajwanshi A
Arch Gynecol Obstet; 2013 Oct; 288(4):873-82. PubMed ID: 23580012
[TBL] [Abstract][Full Text] [Related]
20. Impact of adjuvant pelvic radiotherapy in stage I uterine sarcoma.
Magnuson WJ; Petereit DG; Anderson BM; Geye HM; Bradley KA
Anticancer Res; 2015 Jan; 35(1):365-70. PubMed ID: 25550573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]